IP Library › Assignment 061567/0271

Patent Assignment

Reel/Frame 061567/0271

Assignment of Assignor's Interest

Recorded: 2022-10-27 Pages: 5

View PDF Order Certified Copy

Assignors

FRANK, IAN

Executed: 2017-05-18

LOTZE, MICHAEL T.

Executed: 2017-05-18

Assignee

LION BIOTECHNOLOGIES, INC.

999 SKYWAY ROAD, SUITE 150, SAN CARLOS, CALIFORNIA, 94070

Covered Properties (20)

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,058,728 →

Application: 17/225,993 →

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,179,419 →

Application: 17/233,290 →

Publication: US 2021/0260121

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,123,371 →

Application: 17/233,295 →

Publication: US 2021/0252062

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,141,438 →

Application: 17/233,299 →

Publication: US 2021/0252063

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,304,980 →

Application: 17/459,988 →

Publication: US 2021/0401889

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,311,578 →

Application: 17/480,900 →

Publication: US 2022/0000926

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,351,197 →

Application: 17/480,916 →

Publication: US 2022/0000927

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,351,198 →

Application: 17/480,919 →

Publication: US 2022/0000928

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,344,580 →

Application: 17/480,935 →

Publication: US 2022/0008470

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,266,694 →

Application: 17/480,941 →

Publication: US 2022/0000929

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,364,266 →

Application: 17/548,502 →

Publication: US 2022/0096555

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,369,637 →

Application: 17/548,504 →

Publication: US 2022/0133798

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,344,581 →

Application: 17/547,190 →

Publication: US 2022/0088080

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,351,199 →

Application: 17/547,192 →

Publication: US 2022/0088081

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Application: 17/829,087 →

Publication: US 2022/0378837

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,857,573 →

Application: 17/819,209 →

Publication: US 2022/0378834

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,969,444 →

Application: 17/819,214 →

Publication: US 2022/0387500

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,975,028 →

Application: 17/819,219 →

Publication: US 2022/0387501

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 12,188,048 →

Application: 17/819,909 →

Publication: US 2023/0030883

Restimulation of Cryopreserved Tumor Infiltrating Lymphocytes

Patent: 11,865,140 →

Application: 17/819,910 →

Publication: US 2022/0395534

Related Assignments (1)

Other recorded transfers of the patents in this record — the chain of ownership.

Change of Name Oct 27, 2022

From: LION BIOTECHNOLOGIES, INC.

To: IOVANCE BIOTHERAPEUTICS, INC.

Reel/Frame 061793/0296 →